Deep phenotypical characterization of human CD3+CD56+ T cells by mass cytometry

CD56(+) T cells are a group of pro-inflammatory CD3(+) lymphocytes with characteristics of natural killer cells, being involved in antimicrobial immune defense. Here, we performed deep phenotypic profiling of CD3(+)CD56(+) cells in peripheral blood of normal human donors and individuals sensitized to birch-pollen or/and house dust mite by high-dimensional mass cytometry combined with manual and computational data analysis. A co-regulation between major conventional T-cell subsets and their respective CD3(+)CD56(+) cell counterparts appeared restricted to CD8(+), MAIT, and TCR gamma delta(+) T-cell compartments. Interestingly, we find a co-regulation of several CD3(+)CD56(+) cell subsets in allergic but not in healthy individuals. Moreover, using FlowSOM, we distinguished a variety of CD56(+) T-cell phenotypes demonstrating a hitherto underestimated heterogeneity among these cells. The novel CD3(+)CD56(+) subset description comprises phenotypes superimposed with naive, memory, type 1, 2, and 17 differentiation stages, in part represented by a phenotypical continuum. Frequencies of two out of 19 CD3(+)CD56(+) FlowSOM clusters were significantly diminished in allergic individuals, demonstrating less frequent presence of cells with cytolytic, presumably protective, capacity in these donors consistent with defective expansion or their recruitment to the affected tissue. Our results contribute to defining specific cell populations to be targeted during therapy for allergic conditions.

Automated summary

This study deep phenotypic profiling of CD3(+)CD56(+) cells in both normal individuals and those sensitized to allergens, revealing co-regulation of multiple CD3(+)CD56(+) cell subsets in allergic individuals and a previously underestimated heterogeneity among these cells. Furthermore, using FlowSOM, a variety of CD56(+) T-cell phenotypes were distinguished, highlighting a complexity in these cells that was not fully recognized before. This research sheds light on specific cell populations to target during therapy for allergic conditions.